10 Red Flags In Gynaecological Cancer Pathways That Could Indicate Breach

Medico-Legal insights brought to you by INNEG
Delayed diagnosis in gynaecological cancer is one of the most common grounds for litigation, not simply because cancer was found late, but because clear red-flag opportunities for earlier intervention were missed.
This checklist, based on insights shared by Consultant Gynaecological Oncology Surgeon Mr Moiad Alazzam during INNEG’s September 2025 webinar, “Delayed Diagnosis in Gynaecological Cancer: Breach, Causation and Missed Opportunities.” distils ten recurring pitfalls solicitors should look for when reviewing cases. From persistent postmenopausal bleeding that should have triggered a two-week wait referral, to the failure to escalate when symptoms continue despite “normal” imaging, to missed MDT reviews, unchased scans, or absent documentation of differential diagnoses, each red flag highlights where accepted practice may have slipped into breach. Even issues such as inadequate fertility preservation discussions in younger patients can carry major implications for damages.
This quick-reference tool gives you an at-a-glance way to spot potential breaches in gynaecological cancer cases, saving time when reviewing records and helping you decide where to dig deeper.
About The Speaker

Mr Mo'aid Alazzam
Consultant Gynaecologist and Gynaecological Oncology Surgeon
Mr Moiad Alazzam is a Consultant Gynaecologist and Gynaecological Oncology Surgeon at Oxford University Hospitals. With over 20 years’ experience in minimally invasive and cancer surgery, he is internationally recognised for his expertise in complex procedures and fertility-preserving techniques. He founded GynaeFellow and the British Surgical Academy and regularly contributes to international research, education, and clinical guidelines.
From the Blog